Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000240

Options or other derivatives

  • SVP & Chief Scientific Officer acquired 134,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gross Jane A · SVP & Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-18 Grant or award : show line 1 in the form Stock Option (right to buy) +134,800 134,800 D
Loading xslF345X03/gross.xml…